Raia Drogasil S.A. (OTCMKTS:RADLY – Get Free Report) hit a new 52-week low on Wednesday. The stock traded as low as $2.4550 and last traded at $2.4550, with a volume of 989 shares trading hands. The stock had previously closed at $2.47.
Analysts Set New Price Targets
Separately, Jefferies Financial Group raised shares of Raia Drogasil to a “buy” rating and set a $5.20 target price on the stock in a research report on Sunday, October 18th. One investment analyst has rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $5.20.
Read Our Latest Stock Analysis on Raia Drogasil
Raia Drogasil Stock Down 1.9%
The stock has a 50-day moving average of $3.49 and a two-hundred day moving average of $3.96. The company has a market cap of $3.24 billion and a P/E ratio of 16.40. The company has a debt-to-equity ratio of 0.99, a quick ratio of 0.58 and a current ratio of 1.41.
Raia Drogasil (OTCMKTS:RADLY – Get Free Report) last issued its earnings results on Tuesday, November 3rd. The company reported $0.05 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.05. Raia Drogasil had a net margin of 2.89% and a return on equity of 20.61%. The firm had revenue of $2.22 billion for the quarter, compared to analysts’ expectations of $2.43 billion. On average, research analysts anticipate that Raia Drogasil S.A. will post 0.17 EPS for the current fiscal year.
Raia Drogasil Company Profile
Raia Drogasil, now known as RD Saúde, is a Brazilian health and pharmacy retail company formed in 2011 through the merger of Droga Raia and Drogasil. It operates pharmacy stores under the Raia and Drogasil brands. The company sells prescription and over-the-counter medicines, personal care and beauty products, and other health and wellness goods. It serves customers across Brazil through its retail locations and digital channels, including online ordering and delivery. In addition to pharmacy retail, RD Saúde provides health-related services through its stores and digital platforms.
Featured Articles
- Five stocks we like better than Raia Drogasil
- Palantir’s Political Controversy Is Hiding a Much Bigger Story
- General Motors Faces a Cost Squeeze as Factory Automation Takes Center Stage
- 5 Consumer Discretionary Plays Showing Strength During the Tech Sell-Off
- NVIDIA’s Earnings Were Strong, But Can the Next CEO Keep the Momentum Going?
Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.
